Neurocrine Bioscienc (NQ: NBIX )
152.39
-0.18
(-0.12%)
Streaming Delayed Price
Updated: 1:49 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Neurocrine Bioscienc
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://www.investors.com/wp-content/uploads/2024/04/Stock-neurocrinebio-02-shutt.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Where Neurocrine Biosciences Stands With Analysts
April 10, 2024
Via Benzinga
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://www.investors.com/wp-content/uploads/2019/02/VIDEO-IBDDIFF-NYSE-020819-shutter.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/04/23/Lab-julia-koblitz.jpeg?width=1200&height=800&fit=crop)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Decoding 8 Analyst Evaluations For Neurocrine Biosciences
March 13, 2024
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2022/08/Stock-neurocrinebio-01-shutt.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.marketbeat.com/logos/articles/med_20240416094159_the-5-stocks-most-sold-by-insiders-this-year.jpg)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://www.investors.com/wp-content/uploads/2023/07/Stock-royalcaribbean-cruiseship-02-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/pharma-lab-worker-ai_13.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](https://www.investors.com/wp-content/uploads/2019/07/stock-Hubspot-05-company.jpg)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.